In order to test our hypothesis that metabolic dysregulation has an important role in PAH pathogenesis, in this new study performed on the same rat models, we examined alterations in the protein levels of Ngf, Nfe2l2, Slc2a1, and the restructuring of several metabolic pathways. The gene discussed is NFE2L2; the disease is pulmonary arterial hypertension.